Abstract
Chronic obstructive pulmonary disease (COPD) has been associated with coronary mortality. Yet, data about the association between COPD and acute myocardial infarction (MI) remain scarce. We aimed to study airway obstruction as a predictor of MI and coronary mortality among 5576 Finnish adults who participated in a national health examination survey between 1978 and 1980. Subjects underwent spirometry, had all necessary data, showed no indications of cardiovascular disease at baseline, and were followed up through record linkage with national registers through 2011. The primary outcome consisted of a major coronary event—that is, hospitalization for MI or coronary death, whichever occurred first. We specified obstruction using the lower limit of normal categorization. Through multivariate analysis adjusted for potential confounding factors for coronary heart disease, hazard ratios (HRs) (with the 95% confidence intervals in parentheses) of a major coronary event, MI, and coronary death reached 1.06 (0.79–1.42), 0.84 (0.54–1.31), and 1.40 (1.04–1.88), respectively, in those with obstruction compared to others. However, in women aged 30–49 obstruction appeared to predict a major coronary event, where the adjusted HR reached 4.21 (1.73–10.28). In conclusion, obstruction appears to predict a major coronary event in younger women only, whereas obstruction closely associates with the risk of coronary death independent of sex and age.
Similar content being viewed by others
References
Vogelmeier CF, Criner GJ, Martínez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;6(49):1700214. doi: 10.1183/13993003.00214-2017. http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. Accessed April 2017.
World Health organization (WHO), Medical center, fact sheets about Cardio vascular diseases. http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed April 2017.
World Health organization (WHO), Medical center, fact sheets about COPD. Available from: http://www.who.int/respiratory/copd/en/. Accessed Dec 2016.
Miller J, Edwards LD, Agusti A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107:1376–84. doi:10.1016/j.rmed.2013.05.001.
Ford ES, Wheaton AG, Mannino DM, Presley-Cantrell L, Li C, Croft JB. Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010. Respir Res. 2012;. doi:10.1186/1465-9921-13-115.
Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulm Dis. 2009;4:337–49.
Lange P, Mogelvang R, Marott JL, Vestbo J, Jensen JS. Cardiovascular morbidity in COPD: a study of the general population. COPD. 2010;7:5–10. doi:10.3109/15412550903499506.
Izquierdo JL, Martínez A, Guzmán E, de Lucas P, Rodríguez JM. Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors. Int J Chron Obstruct Pulm Dis. 2010;5:387–94.
Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25:253–60. doi:10.1007/s10654-010-9435-7.
Mullerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD systematic literature review. Chest. 2013;144:1163–78. doi:10.1378/chest.12-2847.
Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128:2068–75.
Mattila T, Vasankari T, Kanervisto M, Laitinen T, Impivaara O, Rissanen H, et al. Association between all-cause and cause-specific mortality and the GOLD stages 1–4: a 30-year follow-up among Finnish adults. Respir Med. 2015;109:1012–8. doi:10.1016/j.rmed.2015.06.002.
Baughman P, Marott JL, Lange P, et al. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol. 2012;27:933–43. doi:10.1007/s10654-012-9750-2.
Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J. 2011;32:2365–75. doi:10.1093/eurheartj/ehr338.
Eriksson B, Lindberg A, Mullerova H, Ronmark E, Lundback B. Association of heart diseases with COPD and restrictive lung function—results from a population survey. Respir Med. 2013;107:98–106. doi:10.1016/j.rmed.2012.09.011.
Rothnie KJ, Yan R, Smeeth L, Quint JK. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 2015;. doi:10.1136/bmjopen-2015-007824.
Ukena C, Mahfoud F, Kindermann M, et al. The cardiopulmonary continuum systemic inflammation as ‘common soil’ of heart and lung disease. Int J Cardiol. 2010;145:172–6. doi:10.1016/j.ijcard.2010.04.082.
Aromaa A, Heliövaara M, Impivaara O, et al. Health, functional limitations and need for care in Finland. Basic results from the Mini-Finland Health Survey (in Finnish with English Summary). Helsinki and Turku, Publications of the Social Insurance Institution 1989. http://hdl.handle.net/10138/162843. Accessed Jan 2017.
Aromaa A, Heliövaara M, Knekt P, Reunanen A, Impivaara O, Maatela J. Cardiovascular and respiratory survey methods. Part 2 (in Finnish with English summary). Helsinki and Turku, Publications of the Social Insurance Institution 1985. http://hdl.handle.net/10138/162384. Accessed Jan 2017.
National Institute for Health and Welfare in Finland. https://www.thl.fi/en/web/thlfi-en/research-and-expertwork/population-studies/finnish-mobile-clinic/mini-finland-health-survey. Accessed Dec 2016.
Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.
Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43. doi:10.1183/09031936.00080312.
Carr JJ, Drekter IJ. Simplified rapid technic for the extraction and determination of serum chlesterol without saponification. Clin Chem. 1956;2:353–68.
Statistics Finland. http://www.stat.fi/index_en.html, http://www.stat.fi/til/ksyyt/2005/ksyyt_2005_2006-10-31_luo_002.html. Accessed 2011.
National Institute for Health and Welfare, Care Register for Health Care (HILMO). In English: https://www.thl.fi/en/web/thlfi-en/statistics/data-collection. In Finnish: https://www.thl.fi/fi/tilastot/tiedonkeruut/hoitoilmoitusjarjestelma-hilmo. Accessed Dec 2016.
Heistaro S. Methodology Report: Heath 2000 Survey. Publications of the National Public Health Institute, Helsinki 2008. http://urn.fi/URN:NBN:fi-fe201204193320.
Bursi F, Vassallo R, Weston SA, Killian JM, Roger VL. Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J. 2010;160:95–101. doi:10.1016/j.ahj.2010.05.004.
Rodríguez LA, Wallander MA, Martín-Merino E, Johansson S. Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study. Respir Med. 2010;104:1691–9. doi:10.1016/j.rmed.2010.04.018.
Hawkins NM, Huang Z, Pieper KS, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2009;11:292–8. doi:10.1093/eurjhf/hfp001.
Andell P, Koul S, Martinsson A, et al. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart. 2014;. doi:10.1136/openhrt-2013-000002.
Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757–67. doi:10.1161/CIRCULATIONAHA.114.009480.
Khamis RY, Ammari T, Mikhail GW. Gender differences in coronary heart disease. Heart. 2016;102:1142–9. doi:10.1136/heartjnl-2014-306463.
Pajunen P, Koukkunen H, Ketonen M, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12:132–7.
Kouzouna A, Gilchrist FJ, Ball V, et al. A systematic review of early life factors which adversely affect subsequent lung function. Paediatr Respir Rev. 2016;20:67–75. doi:10.1016/j.prrv.2016.03.003.
Chu A, De Beritto T. The perinatal origins of cardiovascular disease. Pediatr Ann. 2015;44:e254–9. doi:10.3928/00904481-20151112-07.
Acknowledgements
A Doctoral Candidate Position at the University of Helsinki/Hospital District of Helsinki and Uusimaa (from June 2016) awarded to the first author allowed for the write-up of our analysis. We wish to thank Vanessa Fuller for English-language revisions to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The corresponding author Tiina Mattila completed this study through financial support from the Hospital District of Helsinki and Uusimaa (a Doctoral Candidate Position in the Doctoral Programme of Clinical Research at the University of Helsinki/Hospital District of Helsinki and Uusimaa from June 2016). Statistical analyses in this study were completed by the corresponding author and the National Institute for Health and Welfare in Helsinki, Finland as a function of that agency’s work. All other co-authors completed the work related to this study as a function of their regular duties. The corresponding author and none of the other authors have any relevant conflicts of interest.
Rights and permissions
About this article
Cite this article
Mattila, T., Vasankari, T., Rissanen, H. et al. Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period. Eur J Epidemiol 33, 89–98 (2018). https://doi.org/10.1007/s10654-017-0278-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-017-0278-3